메뉴 건너뛰기




Volumn 86, Issue 3, 2014, Pages 28-33

The clinical aspects of efficiency of the prevention of pneumococcal infection with vaccines in chronic obstructive pulmonary disease patients living in the West Siberian Region

Author keywords

Chronic obstructive pulmonary disease; Clinical efficacy; Pneumo 23 vaccine

Indexed keywords

23 VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE; 23-VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE; PNEUMOCOCCUS VACCINE;

EID: 84901723138     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (7)

References (4)
  • 1
    • 34548222188 scopus 로고    scopus 로고
    • Global burden of COPD: Risk factors, prevalence, and future trends
    • Mannino D. M., Buist A. S. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370:765-773.
    • (2007) Lancet , vol.370 , pp. 765-773
    • Mannino, D.M.1    Buist, A.S.2
  • 3
    • 11244347166 scopus 로고    scopus 로고
    • The economic burden of COPD. Proceeding of the satellite symposium Nol «The Impact of COPD»
    • Madrid
    • Buist SA. The Economic Burden of COPD. Proceeding of the satellite symposium Nol «The Impact of COPD». 9tn European Respiratory Society Annual Congress. Madrid 1999:8-11.
    • (1999) 9tn European Respiratory Society Annual Congress , pp. 8-11
    • Buist, S.A.1
  • 4
    • 33645052436 scopus 로고    scopus 로고
    • Clinical efficiacy of antipneumococcal vaccination in patients with COPD
    • Alfageme I., Vazquez R., Reyes N. et al. Clinical efficiacy of antipneumococcal vaccination in patients with COPD. Thorax 2006;61:189-195.
    • (2006) Thorax , vol.61 , pp. 189-195
    • Alfageme, I.1    Vazquez, R.2    Reyes, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.